Cargando…

Probing Anti-inflammatory Properties Independent of NF-κB Through Conformational Constraint of Peptide-Based Interleukin-1 Receptor Biased Ligands

Interleukin-1β (IL-1β) binds to the IL-1 receptor (IL-1R) and is a key cytokine mediator of inflammasome activation. IL-1β signaling leads to parturition in preterm birth (PTB) and contributes to the retinal vaso-obliteration characteristic of oxygen-induced retinopathy (OIR) of premature infants. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Geranurimi, Azade, Cheng, Colin W. H., Quiniou, Christiane, Zhu, Tang, Hou, Xin, Rivera, José Carlos, St-Cyr, Daniel J., Beauregard, Kim, Bernard-Gauthier, Vadim, Chemtob, Sylvain, Lubell, William D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381024/
https://www.ncbi.nlm.nih.gov/pubmed/30815434
http://dx.doi.org/10.3389/fchem.2019.00023
_version_ 1783396400901390336
author Geranurimi, Azade
Cheng, Colin W. H.
Quiniou, Christiane
Zhu, Tang
Hou, Xin
Rivera, José Carlos
St-Cyr, Daniel J.
Beauregard, Kim
Bernard-Gauthier, Vadim
Chemtob, Sylvain
Lubell, William D.
author_facet Geranurimi, Azade
Cheng, Colin W. H.
Quiniou, Christiane
Zhu, Tang
Hou, Xin
Rivera, José Carlos
St-Cyr, Daniel J.
Beauregard, Kim
Bernard-Gauthier, Vadim
Chemtob, Sylvain
Lubell, William D.
author_sort Geranurimi, Azade
collection PubMed
description Interleukin-1β (IL-1β) binds to the IL-1 receptor (IL-1R) and is a key cytokine mediator of inflammasome activation. IL-1β signaling leads to parturition in preterm birth (PTB) and contributes to the retinal vaso-obliteration characteristic of oxygen-induced retinopathy (OIR) of premature infants. Therapeutics targeting IL-1β and IL-1R are approved to treat rheumatoid arthritis; however, all are large proteins with clinical limitations including immunosuppression, due in part to inhibition of NF-κB signaling, which is required for immuno-vigilance and cytoprotection. The all-D-amino acid peptide 1 (101.10, H-d-Arg-d-Tyr-d-Thr-d-Val-d-Glu-d-Leu-d-Ala-NH(2)) is an allosteric IL-1R modulator, which exhibits functional selectivity and conserves NF-κB signaling while inhibiting other IL-1-activated pathways. Peptide 1 has proven effective in experimental models of PTB and OIR. Seeking understanding of the structural requirements for the activity and biased signaling of 1, a panel of twelve derivatives was synthesized employing the various stereochemical isomers of α-amino-γ-lactam (Agl) and α-amino-β-hydroxy-γ-lactam (Hgl) residues to constrain the D-Thr-D-Val dipeptide residue. Using circular dichroism spectroscopy, the peptide conformation in solution was observed to be contingent on Agl, Hgl, and Val stereochemistry. Moreover, the lactam mimic structure and configuration influenced biased IL-1 signaling in an in vitro panel of cellular assays as well as in vivo activity in murine models of PTB and OIR. Remarkably, all Agl and Hgl analogs of peptide 1 did not inhibit NF-κB signaling but blocked other pathways, such as JNK and ROCK2 phosphorylation contingent on structure and configuration. Efficacy in preventing preterm labor correlated with a capacity to block IL-1β-induced IL-1β synthesis. Furthermore, the importance of inhibition of JNK and ROCK2 phosphorylation for enhanced activity was highlighted for prevention of vaso-obliteration in the OIR model. Taken together, lactam mimic structure and stereochemistry strongly influenced conformation and biased signaling. Selective modulation of IL-1 signaling was proven to be particularly beneficial for curbing inflammation in models of preterm labor and retinopathy of prematurity (ROP). A class of biased ligands has been created with potential to serve as selective probes for studying IL-1 signaling in disease. Moreover, the small peptide mimic prototypes are promising leads for developing immunomodulatory therapies with easier administration and maintenance of beneficial effects of NF-κB signaling.
format Online
Article
Text
id pubmed-6381024
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63810242019-02-27 Probing Anti-inflammatory Properties Independent of NF-κB Through Conformational Constraint of Peptide-Based Interleukin-1 Receptor Biased Ligands Geranurimi, Azade Cheng, Colin W. H. Quiniou, Christiane Zhu, Tang Hou, Xin Rivera, José Carlos St-Cyr, Daniel J. Beauregard, Kim Bernard-Gauthier, Vadim Chemtob, Sylvain Lubell, William D. Front Chem Chemistry Interleukin-1β (IL-1β) binds to the IL-1 receptor (IL-1R) and is a key cytokine mediator of inflammasome activation. IL-1β signaling leads to parturition in preterm birth (PTB) and contributes to the retinal vaso-obliteration characteristic of oxygen-induced retinopathy (OIR) of premature infants. Therapeutics targeting IL-1β and IL-1R are approved to treat rheumatoid arthritis; however, all are large proteins with clinical limitations including immunosuppression, due in part to inhibition of NF-κB signaling, which is required for immuno-vigilance and cytoprotection. The all-D-amino acid peptide 1 (101.10, H-d-Arg-d-Tyr-d-Thr-d-Val-d-Glu-d-Leu-d-Ala-NH(2)) is an allosteric IL-1R modulator, which exhibits functional selectivity and conserves NF-κB signaling while inhibiting other IL-1-activated pathways. Peptide 1 has proven effective in experimental models of PTB and OIR. Seeking understanding of the structural requirements for the activity and biased signaling of 1, a panel of twelve derivatives was synthesized employing the various stereochemical isomers of α-amino-γ-lactam (Agl) and α-amino-β-hydroxy-γ-lactam (Hgl) residues to constrain the D-Thr-D-Val dipeptide residue. Using circular dichroism spectroscopy, the peptide conformation in solution was observed to be contingent on Agl, Hgl, and Val stereochemistry. Moreover, the lactam mimic structure and configuration influenced biased IL-1 signaling in an in vitro panel of cellular assays as well as in vivo activity in murine models of PTB and OIR. Remarkably, all Agl and Hgl analogs of peptide 1 did not inhibit NF-κB signaling but blocked other pathways, such as JNK and ROCK2 phosphorylation contingent on structure and configuration. Efficacy in preventing preterm labor correlated with a capacity to block IL-1β-induced IL-1β synthesis. Furthermore, the importance of inhibition of JNK and ROCK2 phosphorylation for enhanced activity was highlighted for prevention of vaso-obliteration in the OIR model. Taken together, lactam mimic structure and stereochemistry strongly influenced conformation and biased signaling. Selective modulation of IL-1 signaling was proven to be particularly beneficial for curbing inflammation in models of preterm labor and retinopathy of prematurity (ROP). A class of biased ligands has been created with potential to serve as selective probes for studying IL-1 signaling in disease. Moreover, the small peptide mimic prototypes are promising leads for developing immunomodulatory therapies with easier administration and maintenance of beneficial effects of NF-κB signaling. Frontiers Media S.A. 2019-02-13 /pmc/articles/PMC6381024/ /pubmed/30815434 http://dx.doi.org/10.3389/fchem.2019.00023 Text en Copyright © 2019 Geranurimi, Cheng, Quiniou, Zhu, Hou, Rivera, St-Cyr, Beauregard, Bernard-Gauthier, Chemtob and Lubell. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Geranurimi, Azade
Cheng, Colin W. H.
Quiniou, Christiane
Zhu, Tang
Hou, Xin
Rivera, José Carlos
St-Cyr, Daniel J.
Beauregard, Kim
Bernard-Gauthier, Vadim
Chemtob, Sylvain
Lubell, William D.
Probing Anti-inflammatory Properties Independent of NF-κB Through Conformational Constraint of Peptide-Based Interleukin-1 Receptor Biased Ligands
title Probing Anti-inflammatory Properties Independent of NF-κB Through Conformational Constraint of Peptide-Based Interleukin-1 Receptor Biased Ligands
title_full Probing Anti-inflammatory Properties Independent of NF-κB Through Conformational Constraint of Peptide-Based Interleukin-1 Receptor Biased Ligands
title_fullStr Probing Anti-inflammatory Properties Independent of NF-κB Through Conformational Constraint of Peptide-Based Interleukin-1 Receptor Biased Ligands
title_full_unstemmed Probing Anti-inflammatory Properties Independent of NF-κB Through Conformational Constraint of Peptide-Based Interleukin-1 Receptor Biased Ligands
title_short Probing Anti-inflammatory Properties Independent of NF-κB Through Conformational Constraint of Peptide-Based Interleukin-1 Receptor Biased Ligands
title_sort probing anti-inflammatory properties independent of nf-κb through conformational constraint of peptide-based interleukin-1 receptor biased ligands
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381024/
https://www.ncbi.nlm.nih.gov/pubmed/30815434
http://dx.doi.org/10.3389/fchem.2019.00023
work_keys_str_mv AT geranurimiazade probingantiinflammatorypropertiesindependentofnfkbthroughconformationalconstraintofpeptidebasedinterleukin1receptorbiasedligands
AT chengcolinwh probingantiinflammatorypropertiesindependentofnfkbthroughconformationalconstraintofpeptidebasedinterleukin1receptorbiasedligands
AT quiniouchristiane probingantiinflammatorypropertiesindependentofnfkbthroughconformationalconstraintofpeptidebasedinterleukin1receptorbiasedligands
AT zhutang probingantiinflammatorypropertiesindependentofnfkbthroughconformationalconstraintofpeptidebasedinterleukin1receptorbiasedligands
AT houxin probingantiinflammatorypropertiesindependentofnfkbthroughconformationalconstraintofpeptidebasedinterleukin1receptorbiasedligands
AT riverajosecarlos probingantiinflammatorypropertiesindependentofnfkbthroughconformationalconstraintofpeptidebasedinterleukin1receptorbiasedligands
AT stcyrdanielj probingantiinflammatorypropertiesindependentofnfkbthroughconformationalconstraintofpeptidebasedinterleukin1receptorbiasedligands
AT beauregardkim probingantiinflammatorypropertiesindependentofnfkbthroughconformationalconstraintofpeptidebasedinterleukin1receptorbiasedligands
AT bernardgauthiervadim probingantiinflammatorypropertiesindependentofnfkbthroughconformationalconstraintofpeptidebasedinterleukin1receptorbiasedligands
AT chemtobsylvain probingantiinflammatorypropertiesindependentofnfkbthroughconformationalconstraintofpeptidebasedinterleukin1receptorbiasedligands
AT lubellwilliamd probingantiinflammatorypropertiesindependentofnfkbthroughconformationalconstraintofpeptidebasedinterleukin1receptorbiasedligands